Literature DB >> 34912998

Impact of a telemedicine-guided, population-based, STEMI network on reperfusion strategy, efficiency, and outcomes: Impact of telemedicine on STEMI management.

Sameer Mehta1, Haytham Aboushi1, Carlos Campos2, Roberto Botelho3, Francisco Fernandez4, Daniel Rodriguez1, Mario Torres1, Daniel Vieria1, Alejandra Frauenfelder1, Gladys Pinto1, Claudia Lopez1, Maria Acosta1.   

Abstract

AIMS: A telemedicine-guided strategy increases the access to and efficiency of ST-elevation myocardial infarction (STEMI) networks resulting in increased access to, and reduced disparities in, acute myocardial infarction (AMI) care between rural and urban areas. METHODS AND
RESULTS: The Latin America Telemedicine Infarct Network (LATIN) was developed for poor and remote regions in Brazil and Colombia that lacked coordinated AMI systems of care. It strategically connects small clinics and primary care health centres (spokes) to hubs with 24/7 percutaneous coronary intervention (PCI) capability. Experts at three remote sites provide urgent electrocardiogram (ECG) diagnosis and tele-consultation for the entire network. Data from the busiest LATIN site, the Santa Marcelina Hospital in Sao Paolo, Brazil, were compared with health statistics from Sistema Unico de Saude (Brazilian Public Health System - SUS). A total of 192 centres were networked using standardised and guideline-based protocols for AMI care. Overall, 313,897 patients were remotely screened, 3,572 AMI diagnosed (1.1%), and 1,636 AMI urgently reperfused (45.8%), mainly by primary PCI (n=1,351; 83%).
CONCLUSIONS: In conclusion, a comparison between a pre-LATIN cohort from SUS (1,015) and a LATIN cohort from Santa Marcelina Hospital (1,247) revealed increased reperfusion with PCI (65.52% vs 75.2%), increased cost ($2,037.12 vs $2,246.40, p<0.005), a statistically significant reduction in PCI mortality (8.5% vs 4.3% p<0.01) and a non-significant reduction in mortality overall amongst all treatment pathways (9.69% vs 9.43%, p=0.931).

Entities:  

Year:  2021        PMID: 34912998      PMCID: PMC8657047          DOI: 10.4244/AIJ-D-18-00047

Source DB:  PubMed          Journal:  AsiaIntervention        ISSN: 2426-3958


  26 in total

1.  Complete Immediate Revascularization of the Patient With ST-Segment-Elevation Myocardial Infarction Is the New Standard of Care.

Authors:  Keith G Oldroyd
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

2.  Reduction of Ischemic Time for Transferred STEMI Patients Using a Smartphone Social Network System.

Authors:  Jin Joo Park; Chang-Hwan Yoon; Jung-Won Suh; Young-Seok Cho; Tae-Jin Youn; In-Ho Chae; Dong-Ju Choi
Journal:  J Am Coll Cardiol       Date:  2016-09-27       Impact factor: 24.094

3.  Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).

Authors:  Abhiram Prasad; Bernard J Gersh; Roxana Mehran; Bruce R Brodie; Sorin J Brener; José M Dizon; Alexandra J Lansky; Bernhard Witzenbichler; Ran Kornowski; Giulio Guagliumi; Dariusz Dudek; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2015-12-28       Impact factor: 11.195

4.  Rural Patient Access to Primary Percutaneous Coronary Intervention Centers is Improved by a Novel Integrated Telemedicine Prehospital System.

Authors:  Alain Tanguay; Renée Dallaire; Denise Hébert; François Bégin; Richard Fleet
Journal:  J Emerg Med       Date:  2015-07-26       Impact factor: 1.484

Review 5.  Moving From Digitalization to Digitization in Cardiovascular Care: Why Is it Important, and What Could it Mean for Patients and Providers?

Authors:  Steven R Steinhubl; Eric J Topol
Journal:  J Am Coll Cardiol       Date:  2015-09-29       Impact factor: 24.094

Review 6.  Comparison of Outcomes of ST-Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention During Off-Hours Versus On-Hours.

Authors:  Tariq H Enezate; Jad Omran; Ashraf S Al-Dadah; Martin Alpert; Ehtisham Mahmud; Mitul Patel; Herbert D Aronow; Deepak L Bhatt
Journal:  Am J Cardiol       Date:  2017-08-04       Impact factor: 2.778

7.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Borja Ibanez; Stefan James; Stefan Agewall; Manuel J Antunes; Chiara Bucciarelli-Ducci; Héctor Bueno; Alida L P Caforio; Filippo Crea; John A Goudevenos; Sigrun Halvorsen; Gerhard Hindricks; Adnan Kastrati; Mattie J Lenzen; Eva Prescott; Marco Roffi; Marco Valgimigli; Christoph Varenhorst; Pascal Vranckx; Petr Widimský
Journal:  Eur Heart J       Date:  2018-01-07       Impact factor: 29.983

8.  Policy recommendations to guide the use of telemedicine in primary care settings: an American College of Physicians position paper.

Authors:  Hilary Daniel; Lois Snyder Sulmasy
Journal:  Ann Intern Med       Date:  2015-09-08       Impact factor: 25.391

9.  Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.

Authors:  Carlos G Santos-Gallego; Torsten P Vahl; Georg Goliasch; Belen Picatoste; Teresa Arias; Kiyotake Ishikawa; Ida U Njerve; Javier Sanz; Jagat Narula; Partho P Sengupta; Roger J Hajjar; Valentin Fuster; Juan J Badimon
Journal:  Circulation       Date:  2016-01-29       Impact factor: 29.690

10.  Using a Cloud Computing System to Reduce Door-to-Balloon Time in Acute ST-Elevation Myocardial Infarction Patients Transferred for Percutaneous Coronary Intervention.

Authors:  Chi-Kung Ho; Fu-Cheng Chen; Yung-Lung Chen; Hui-Ting Wang; Chien-Ho Lee; Wen-Jung Chung; Cheng-Jui Lin; Shu-Kai Hsueh; Shin-Chiang Hung; Kuan-Han Wu; Chu-Feng Liu; Chia-Te Kung; Cheng-I Cheng
Journal:  Biomed Res Int       Date:  2017-08-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.